Short answer · Medically reviewed summary · Last updated: 2026-05-08
Factor V deficiency, also known as Owren's disease or parahemophilia, is a rare bleeding disorder managed primarily through the replacement of clotting factors during bleeding episodes or prior to surgery. Because there is no commercially available purified Factor V concentrate, treatment typically involves the administration of fresh frozen plasma (FFP) to replenish the missing protein. What are the current first-line treatments for Factor V deficiency? Management of Factor V deficiency is highly individualized based on the severity of the bleeding symptoms.
What are the best treatments for Factor V Deficiency?
Treatments for Factor V Deficiency: what real patients say works for them, alongside a medically reviewed overview citing sources like NIH GARD and Orphanet.
Factor V deficiency, also known as Owren's disease or parahemophilia, is a rare bleeding disorder managed primarily through the replacement of clotting factors during bleeding episodes or prior to surgery. Because there is no commercially available purified Factor V concentrate, treatment typically involves the administration of fresh frozen plasma (FFP) to replenish the missing protein.
What are the current first-line treatments for Factor V deficiency?
Management of Factor V deficiency is highly individualized based on the severity of the bleeding symptoms. There is no standard prophylactic medication, so treatment focuses on on-demand therapy. The primary goal is to increase plasma levels of the Factor V protein to a point where hemostasis (blood clotting) can occur effectively. Since Factor V deficiency is rare, with an estimated prevalence of 1 in 1,000,000 people, treatment protocols are often guided by expert consensus rather than large-scale clinical trials.
What medications and therapies are used for Factor V deficiency?
Patients with Factor V deficiency require careful coordination with hematologists. Common interventions include:
- Fresh Frozen Plasma (FFP): The standard therapy, providing the necessary Factor V protein to stop active bleeding or prepare for invasive procedures.
- Platelet Transfusions: Because a significant portion of the body's Factor V is stored in platelets, these may be used if FFP is insufficient.
- Antifibrinolytics: Medications such as tranexamic acid or aminocaproic acid (Amicar) may be used as adjuncts to stabilize clots, particularly for mucosal bleeding.
- Topical Agents: Fibrin sealants or topical thrombin may be applied locally to manage minor wounds or dental extraction sites.
Which specialists should be on the care team for Factor V deficiency?
Managing Factor V deficiency requires a multidisciplinary approach to address the unique bleeding risks of each patient. Your core team should include a hematologist specializing in coagulation disorders, a clinical geneticist for family counseling, and a dentist or surgeon experienced in managing patients with bleeding diatheses. Because Factor V deficiency can vary from mild to severe, your care team must regularly monitor your specific clinical response to plasma therapy.
Next steps
- Consult a hematologist specializing in rare bleeding disorders to establish an emergency bleeding plan.
- Join the Factor V deficiency community at DiseaseMaps.org to connect with others sharing their experiences.
- Wear a medical alert bracelet identifying your condition to ensure proper care during emergencies.
Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice; please consult your physician for personalized treatment plans.
References
- NIH Genetic and Rare Diseases Information Center (GARD): Factor V deficiency.
- Orphanet: Rare bleeding disorder, Factor V deficiency.
- OMIM (Online Mendelian Inheritance in Man): Factor V deficiency entry #227400.
- World Federation of Hemophilia (WFH) Guidelines on the management of rare bleeding disorders.
